Lupus News

The risk for hospital-diagnosed COVID-19 among patients with autoimmune or immune-mediated disease may depend on age, specific disease and prior therapy, according to data published in the Annals of the Rheumatic Diseases.

With many patients avoiding in-office visits due to COVID-19 concerns, self-management in lupus is more important than ever, according to a presenter at the 2020 Rheumatology Nurses Society Annual Conference.

Higher Blymphocyte stimulator and low interleukin-10 levels among cigarette smokers, particularly women who are positive for antinuclear antibodies, are associated with an increased risk for systemic lupus erythematosus, researchers noted.

Despite advances in care, Asian patients hospitalized for systemic lupus erythematosus are at a 79% greater risk for death than white patients hospitalized with the same disease, according to data published in Arthritis Care & Research.

Understanding the myriad cutaneous manifestations of conditions like systemic lupus erythematosus will aid rheumatologists in providing better care for their patients, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.

A lack of EULAR/European Renal Association-European Dialysis and Transplant Association response at 1 year among patients with lupus nephritis predicted chronic kidney disease, researchers reported.

In a cohort of pregnant women with prior maternal congenital heart block, hydroxychloroquine successfully reduced the risk for recurrent fetal blocks by more than 50%, according results from the PATCH trial.

Among Medicaid-insured women with systemic lupus erythematosus, Black and Asian patients are less likely than white patients to receive contraceptives from a health provider, according to data published in Arthritis Care & Research.

An estimated 2.95 million children and young people worldwide live with clubfoot, juvenile idiopathic arthritis or juvenile systemic lupus erythematosus, with the greatest prevalence in South Asia, researchers reported.

Patients with systemic lupus erythematosus demonstrated a 27% higher risk for nonfatal cardiovascular events compared with patients with diabetes, and twice the risk of the general population, according data published in Arthritis Care & Research.